🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock

Recruitingn/aAges 18 Years - anyAllWroclaw Medical University
NCT06697093 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The registry objective is to get information on current epidemiology, diagnostics, treatment and outcome in patients with cardiogenic shock in Poland. Obtained information will help to plan the nationwide initiative for modern cardiogenic shock treatment with established place for mechanical circulatory support. It is hypothesized that the treatment and outcome of cardiogenic shock, including mechanical circulatory support, are currently poor in Poland and should be improved. Unfortunately, without status quo data, efficient planning for its improvement cannot be conducted, hence the CaS-POL registry initiative.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Cardiogenic shock patients of all etiologies in SCAI stage B, C, D, E. * age \> 18 years old * persistent hemodynamic failure defined as systolic blood pressure of \<90 mmHg for ≥ 30 minutes or the requirement for inotropic or vasopressor agents with evidence of hypoperfusion of the peripheral organs Exclusion Criteria: * patients without return of spontaneous circulation who were considered to extracorporeal cardiopulmonary resuscitation (ECPR) * primary septic, anaphylactic, hypovolemic shock * post-operative cardiogenic shock * end-stage of heart failure disqualified from mechanical circulatory support and heart transplantation
💊

What it tests

  • Not listed
📍

Where

2 sites
Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland
Wroclaw, Poland
Wroclaw Medical University
Wroclaw, Poland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy